Skip to content
Clinical Trials – home
IrelandBack to Ireland

Clinical trials in Drogheda – page 21

324 clinical trials in Drogheda, Ireland. Every trial is listed in the EU Clinical Trials Register and updated daily.

Drogheda at a glance
324
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

324 trials in Drogheda

Open in trial search

Study of utreloxastat (PTC857) in adults with Amyotrophic Lateral Sclerosis (ALS) to evaluate its effectiveness in slowing disease progression

Investigational
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Sponsor:PTC Therapeutics Inc.

Plasma cell myeloma

Not recruiting

Study on Alnuctamab and Drug Combination for Patients with Relapsed or Refractory Multiple Myeloma

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Alnuctamab
  • Sponsor:Celgene International II S.a.r.l.

Study on Tafasitamab and Lenalidomide with Standard Therapy for Newly Diagnosed High-Risk Diffuse Large B-Cell Lymphoma Patients

Registered drug
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Cyclophosphamide
  • Sponsor:Incyte Corp.

Long-Term Study of BI 1015550 for Patients with Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis

InvestigationalNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Nerandomilast
  • Sponsor:Boehringer Ingelheim Espana S.A.

Osteochondrodysplasia

Not recruiting

Study on the Effects of Navepegritide and Lonapegsomatropin in Children with Achondroplasia

InvestigationalNo placebo
Countries:IrelandIreland
  • Participants:0–17 years
  • Substances:Lonapegsomatropin
  • Sponsor:Ascendis Pharma Growth Disorders A/S

Study Comparing INBRX-101 and Human Alpha1-Proteinase Inhibitor for Adults with Alpha-1 Antitrypsin Deficiency Emphysema

Registered drug
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Sponsor:Sanofi AATD Inc.

Study of Mavacamten for Adolescents with Symptomatic Obstructive Hypertrophic Cardiomyopathy

Investigational
Countries:IrelandIreland
  • Participants:0–17 years
  • Substances:Mavacamten
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

HIV infection+1

Not recruiting

Study on Semaglutide for Weight Loss in Patients with HIV and Obesity

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Semaglutide
  • Sponsor:University College Dublin

Adenocarcinoma gastric+1

Not recruiting

Study of Pembrolizumab with Chemotherapy for Patients with Advanced Gastric or Gastroesophageal Junction Cancer

Registered drug
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Merck Sharp & Dohme LLC

Study of Relatlimab and Nivolumab with Chemotherapy for Patients with Stage IV or Recurrent Non-Small Cell Lung Cancer

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Iron deficiency anaemia+1

Not recruiting

Study on Daily vs. Alternate Day Iron Supplements for Treating Iron Deficiency Anemia in Pregnant Women

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years
  • Substances:Iron
  • Sponsor:University College Dublin

Uveal melanoma+2

Not recruiting

Study on the Effectiveness and Safety of Belzupacap Sarotalocan for Patients with Small Choroidal Melanoma or Indeterminate Lesions

Investigational
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Sponsor:Aura Biosciences Inc.

Other cities in Ireland

The busiest research cities in the country

All 16 cities in Ireland

Clinical research in Drogheda

What the registry says about research in the country

01 Gastrointestinal Disorders

Innovative research focusing on inflammatory bowel diseases, including trials evaluating new therapeutic approaches for ulcerative colitis and Crohn's disease. Studies are examining novel compounds like obefazimod for improving patient outcomes.

  • Ulcerative Colitis Management
  • Crohn's Disease Treatment
  • Celiac Disease Therapy

Multiple trials are investigating endoscopic improvement and symptomatic remission in patients with moderate to severe conditions.

02 Infectious Disease Prevention

Groundbreaking research in preventing and treating various infections, with particular focus on Clostridioides difficile infection recurrence and surgical site infections following abdominal procedures.

  • Post-Surgical Infection Prevention
  • C. difficile Treatment
  • Anti-infective Therapies

Studies are evaluating novel preventive measures and treatment approaches to reduce infection rates.

03 Dermatological Conditions

Clinical research examining treatments for chronic skin conditions, with emphasis on Hidradenitis Suppurativa. Trials are evaluating new biological therapies like lutikizumab for moderate to severe cases.

  • Inflammatory Skin Diseases
  • Novel Biological Treatments
  • Chronic Condition Management

Research focuses on improving symptoms and quality of life for patients with persistent skin disorders.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.